A randomised, double-blind, parallel-group trial to investigate the efficacy and tolerability of radiotherapy as prophylactic treatment against the development of CASODEX monotherapy induced gynaecomastia and breast pain in prostate cancer patients.
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
No locations available